Author: Lily Yushko

RxPATH Study – Improving Hypertension Detection and Control through a Hypertension Certification Program Based Upon the Hypertension Canada Guidelines

Posted on Lily YushkoPosted in Highlighted Project

Background/Rationale: Hypertension is the leading cause of death and disability worldwide, accounting for more than one tenth (13%) of the total deaths every year. Hypertension control is still elusive despite its complications (e.g., heart disease, stroke and kidney failure) and advances in treatment. Levels of hypertension awareness and control have increased in Canada over the […]

Outcomes of Urinary Tract Infection Management by Pharmacists: RxOUTMAP

Posted on Lily YushkoPosted in Highlighted Project

  RxOUTMAP tracks and quantifies the impact of pharmacist management of patients with uncomplicated urinary tract infections. Background Urinary tract infection (UTI) is one of the most common indications for which antibacterial agents are initiated. It is also the 8th most common reason for ambulatory clinic visits and the 5th most common reason for emergency […]

A Quality Improvement Project to Address lower urinary tract symptoms (LUTS) by pharmacists in the community (PILUTS)

Posted on Lily YushkoPosted in Highlighted Project

Purpose: To determine if pharmacists in the community improve patient management of lower urinary tract symptoms. Setting: Community pharmacies in Edmonton and surrounding area Participants: Seniors who come to the community pharmacy Design: randomized controlled trial Control group: Pharmacist asks some assessment questions about LUTS Pharmacist determines the baseline scores on the patient questionnaire Pharmacist […]

Improving Stroke Prevention in Atrial Fibrillation through Pharmacist Prescribing: PIAAF

Posted on Lily YushkoPosted in Uncategorised

Your browser does not support the video tag. Lead Investigators Dr. Roopinder Sandhu MD, MPH and Dr. Ross Tsuyuki BSc Pharm, PharmD,MSc Study Sponsor Heart and Stroke Foundation of Canada, Canadian Stroke Prevention Intervention Network (C-SPIN) & University of Alberta Hospital Foundation Central Coordinating Centre EPICORE/SPOR, Department of Medicine, University of Alberta Background Atrial fibrillation […]

Review of Education on ACE Inhibitors in Congestive Heart Failure Treatment

Posted on Lily YushkoPosted in Completed Project

Primary Objective: To determine the effect of an in-hospital intervention in patients with congestive heart failure on the use of ACEIs. Secondary Objective: To determine the effect of a patient-centered support program started prior to hospital discharge in patients with CHF, by evaluating: ACEI persistence and discontinuation ACEI use ACEI dosage titration its economic implications […]

Pharmacist Identification of New, Diagnostically Confirmed Osteoarthritis

Posted on Lily YushkoPosted in Completed Project

This is a study to determine the feasibility and accuracy of a pharmacist-screening program to identify people with UNDIAGNOSED knee osteoarthritis. PHIND-OA has been completed and an abstract was accepted at the European League Against Rheumatism Meeting in Amsterdam in late June. The study, led by Dr. Carlo Marra of the University of British Columbia, […]

A Randomized Trial of a Community Pharmacist-Initiated Screening and Intervention Program for Osteoporosis – The OsteoPharm Study

Posted on Lily YushkoPosted in Completed Project

Study Objective: The objective of this study is to determine the effect of a community pharmacist-initiated multifaceted intervention on the diagnosis and treatment of osteoporosis in patients at high risk of fracture. The primary outcome of this study is a composite endpoint reflecting improvement in the overall quality of osteoporosis care (performance of a formal […]